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A simple, highly efficient method for heterologous expression 
in mammalian primary neurons using cationic lipid-mediated 
mRNA transfection
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Expression of heterologous proteins in adult mammalian neurons is a valuable technique for 
the study of neuronal function. The post-mitotic nature of mature neurons prevents effective 
DNA transfection using simple, cationic lipid-based methods. Adequate heterologous protein 
expression is often only achievable using complex techniques that, in many cases, are associated 
with substantial toxicity. Here, a simple method for high efficiency transfection of mammalian 
primary neurons using in vitro transcribed mRNA and the cationic lipid transfection reagent 
Lipofectamine™ 2000 is described. Optimal transfection conditions were established in adult 
mouse dissociated dorsal root ganglion (DRG) neurons using a 96-well based luciferase activity 
assay. Using these conditions, a transfection efficiency of 25% was achieved in DRG neurons 
transfected with EGFP mRNA. High transfection efficiencies were also obtained in dissociated 
rat superior cervical ganglion (SCG) neurons and mouse cortical and hippocampal cultures. 
Endogenous Ca2+ currents in EGFP mRNA-transfected SCG neurons were not significantly 
different from untransfected neurons, which suggested that this technique is well suited for 
heterologous expression in patch clamp recording experiments. Functional expression of a 
cannabinoid receptor (CB1R), a G protein inwardly rectifying K+ channel (GIRK4) and a dominant-
negative G protein α-subunit mutant (GoA G203T) indicate that the levels of heterologous protein 
expression attainable using mRNA transfection are suitable for most functional protein studies. 
This study demonstrates that mRNA transfection is a straightforward and effective method for 
heterologous expression in neurons and is likely to have many applications in neuroscience 
research.
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(Ehrengruber et al., 2001). Unfortunately, the relatively long period 
between transduction of neurons and sufficient transgene expres-
sion can be a problem: extended culture may be difficult for some 
types of neuron and often results in substantial neurite growth that 
makes reliable voltage-clamp experiments difficult to carry out. 
In addition, preparation of lentiviral vectors is time-consuming 
and appropriate laboratory safety considerations are necessary. 
Intranuclear microinjection of cDNA provides a reliable method 
for heterologous protein expression, which is suitable for single-
cell assays such as electrophysiology and many imaging-based 
techniques (Lu et al., 2009), but this approach requires consider-
able equipment, user expertise and is a rather laborious task. The 
absence of a simple and effective method for heterologous protein 
expression in neurons restricts many experiments to other models 
such as cell lines, which may lack many of the characteristics of 
primary neurons. Therefore, development of such a method would 
be a valuable tool for neuroscience research.
The post-mitotic nature of neurons is likely to be the reason 
why cationic lipid-mediated DNA transfection is inefficient in 
neurons. Previous studies have shown that the nuclear envelope 
is the major barrier to successful of cationic lipid-mediated trans-
fection (Zabner et al., 1995) and breakdown of nuclear envelope 
during mitosis is thought to be the primary route for entry of 
IntroductIon
Heterologous protein expression in primary neurons is a valuable 
technique for the study of neuronal function, which allows the 
roles of specific proteins to be studied in a physiologically relevant 
environment. Heterologous expression from plasmid cDNA vectors 
using simple cationic lipid-based transfection methods are effective 
in dividing cells, but often result in very low transfection efficien-
cies in post-mitotic cells such as mature neurons. As a result, these 
methods are unsuitable for many studies and, when used, raise 
the question of how well the few successfully transfected neurons 
represent the population of neurons under investigation.
Other methods for heterologous expression in neurons have 
been developed but most have significant drawbacks. A modi-
fied electroporation method, “nucleofection,” can produce high 
transfection efficiency and minimal toxicity in dissociated hip-
pocampal neuron cultures (Teruel et al., 1999), but, in our lab, it 
has been difficult to apply this technique to peripheral ganglion 
neurons without altering the electrophysiological properties of the 
cells (unpublished observations). Biolistic gene transfer is a simple 
and rapid technique for heterologous expression in neurons, but is 
associated with substantial cell death and has a relatively low trans-
fection efficiency (Wellmann et al., 1999). Lentiviral vectors can 
efficiently transduce hippocampal slice cultures with low  toxicity 
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of culture medium and plated in three poly-l-lysine-coated 35 mm 
Petri dishes. Neurons were cultured for approximately 16 h at 37°C 
prior to further experiments.
Hippocampal and cerebral cortical tissues were dissected from 
P0 to P1 Sprague Dawley rats and enzymatically dissociated using 
papain, as previously described (Thaler et al., 2009). Cells were 
plated on poly-l-lysine-coated glass-bottomed 35 mm dishes and 
incubated at 37°C for 5 days prior to transfection.
Molecular bIology
Standard PCR- and restriction-based cloning techniques were 
used to construct the cDNA plasmids (from which the mRNA 
was transcribed) in this study. Full details and plasmid vec-
tor maps are provided in the Supplementary Material. Briefly, 
cDNA was cloned into a custom-made pCI-based plasmid vec-
tor (Promega, Madison, WI, USA) containing an optimized T7 
promoter and a tandem of human β-globin 3′-UTRs, as pre-
viously described (Williams et al., 2009). The following coding 
sequences were cloned into the vector: Renilla luciferase (hRluc, 
from phRG-TK) and firefly luciferase (+luc from pGL3-Control; 
both from Promega); human cannabinoid receptor 1 (CNR1 tran-
script variant 1; NM_016083); rat G protein-coupled inwardly 
rectifying K+ channel subtype 4 (GIRK4; Kcnj5; NM_017297) 
containing the S143T mutation, which is capable of forming 
homomeric channels (Vivaudou et al., 1997); human heterot-
rimeric G protein α-subunit G
oA
 (GNAO1 transcript variant 1; 
NM_02098) containing the G203T “dominant-negative” muta-
tion (Slepak et al., 1993).
mRNA was transcribed from linearized plasmid DNA using 
mMESSAGE mMACHINE T7 kit. mRNA was recovered from the 
transcription reaction using lithium chloride precipitation accord-
ing to the manufacturer’s instructions (Ambion, Austin, TX, USA). 
mRNA were resuspended in RNase-free H
2
O, split into 10 μl aliq-
uots and stored at −70°C. The integrity of the mRNA was assessed 
on a formaldehyde agarose gel. Concentrations were determined 
using a Biophotometer (Eppendorf, Hamburg, Germany) by meas-
uring the absorbance at 260 nm.
transfectIon
The transfection mix consisted of mRNA, Lipofectamine™ 2000 
(L2K) and OptiMEM (both from Life Technologies, Carlsbad, 
CA, USA). For the luciferase assays, a total volume of 65 μl was 
used per transfection. For all other experiments (carried out in 
35 mm dishes), a total volume of 2 ml was used for each trans-
fection. The quantities of L2K and mRNA for each experiment 
are specified in the section “Results.” The transfection mix was 
prepared in two parts of equal volume: one part containing the 
RNA, the second part containing L2K. Each component was gen-
tly mixed, incubated at room temperature for 5 min before being 
combined, mixed again, and incubated at room temperature for 
a further 30 min. Cells were incubated with the transfection 
mix for the length of time described in the section “Results.” 
Following incubation, cells were washed twice with PBS and 
culture media added and incubated at 37°C, until experiments 
were performed. Protocols for transfection of adherent neurons 
and neurons in suspension in a 35 mm dish are provided in the 
Supplementary Material.
foreign DNA into the nucleus (Mortimer et al., 1999; Brunner 
et al., 2000). mRNA translation takes place in the cytosol and there-
fore protein expression from exogenous mRNA does not require 
entry into the nucleus. For this reason, mRNA transfection has the 
potential to be an efficient method for heterologous expression in 
post-mitotic cells such as primary neurons. While cationic lipid-
mediated transfection of mRNA was developed some time ago 
(Malone et al., 1989), its potential for transfection of non-dividing 
cells has only recently been demonstrated (Van Tendeloo et al., 
2007; Zou et al., 2010).
In these studies, we describe a simple method for high efficiency 
transfection of primary neurons using in vitro transcribed mRNA 
and the cationic lipid reagent, LipofectamineTM 2000 (L2K). Using 
this mRNA transfection protocol, heterologous expression of func-
tional receptors and channels capable of coupling to endogenous 
signaling pathways is shown. This method appears to be of low 
toxicity and levels of protein expression are shown to be sufficiently 
high to conduct a dominant-negative experiment.
Methods
PrIMary neuron cultures
All animals were sacrificed using methods in accordance with the 
NIH Guidelines for Animal Care and Use. To prepare dissociated 
DRG neurons, approximately 40 ganglia from 2- to 4-month-old 
Swiss Webster or C57BL/6 mice were removed from cervical, tho-
racic and lumbar levels of the spine. Ganglia were combined and 
dissociated enzymatically with 1 mg/ml collagenase type D and 
0.3 mg/ml trypsin (both from Worthington Biochemical Corp, 
Lakewood, NJ, USA) in Earle’s Balanced Salt Solution (EBSS) 
saturated with 5% CO
2
/95% O
2
 in a shaking incubator at 37°C 
for 1 h. After this digestion step, neurons were dissociated by vig-
orous shaking of the flask by hand for 10 s. The cells were then 
washed and spun at 50 × g twice for 6 min, and resuspended in 
culture medium consisting of minimal essential medium (MEM; 
Life Technologies, Carlsbad, CA, USA) supplemented with 10% 
fetal bovine serum (Hyclone, Logan, UT, USA) and 1 unit/ml peni-
cillin, 1 µg/ml streptomycin (Life Technologies). For luciferase 
assays, DRG neurons from two mice were plated into 48 wells of 
a poly-l-lysine-coated 96-well plate (Corning, Lowell, MA, USA). 
For imaging experiments, DRG neurons from one mouse were 
plated on poly-l-lysine-coated glass-bottomed 35 mm Petri dishes 
(MatTek, Ashland, MA, USA).
Superior cervical ganglion neurons from male adult Wistar rats 
(200–250 g) were dissociated enzymatically according to the pro-
tocol described previously (Ikeda, 2004) with the following modi-
fications: after the first wash and spin of dissociated neurons, the 
cells were resuspended in 10 ml of OptiMEM (Life Technologies) 
and then split into a 4-ml and a 6-ml aliquot. The cells were cen-
trifuged a second time and the 4-ml aliquot (control cells) was 
resuspended in 400 μl of culture medium and plated in two poly-
l-lysine-coated 35 mm Petri dishes. The second aliquot of cells 
(6 ml) was spun down and resuspended in 2 ml of the transfection 
mix (described below). The cell suspension was transferred to a 
0.15% agar-coated 35 mm dish and incubated for 1 h at 37°C. 
After the incubation, 3 ml of the culture medium was added to 
the cells and the suspension was transferred to a 15 ml centrifuge 
tube. The neurons were spun at 50 × g, and resuspended in 600 μl 
www.frontiersin.org November 2010 | Volume 4 | Article 181 | 3
Williams et al. mRNA transfection of neurons
USA) and fire-polished to a final resistance of approximately 5 MΩ 
when filled with internal solution. Voltage protocol generation and 
data acquisition were carried out using custom designed software 
(S5) running on a Mac G4 computer (Apple, Cupertino, CA, USA). 
Currents were filtered at 10 kHz using a four-pole low-pass Bessel 
filter, and digitized at 10 kHz. Uncompensated series resistance 
was <6 MΩ and was electrically compensated to approximately 
90%. For Ca2+ currents, the external solution contained (in mM): 
145 tetraethylammonium hydroxide (TEA-OH), 140 methanesul-
fonate, 10 HEPES, 15 glucose, and 10 CaCl
2
, and 0.0003 tetrodo-
toxin (TTX). Internal pipette solution contained (in mM): 120 
N-methyl-d-glucamine, 20 TEA-OH, 10 HEPES, 11 EGTA, 1 CaCl
2
, 
14 Tris-creatine phosphate, 4 MgATP, and 0.3 Na
2
GTP. For GIRK 
currents, the external solution contained (in mM): 130 NaCl, 5.4 
KCl, 10 HEPES, 0.8 MgCl
2
, 10 CaCl
2
, 15 glucose, 15 sucrose, and 
0.0003 TTX. GIRK internal pipette solution contained (in mM): 
135 KCl, 11 EGTA, 1 CaCl
2
, 2 MgCl
2
, 10 HEPES, 4 MgATP, and 0.3 
Na
2
GTP. The pH of the solutions were adjusted to 7.4. All recordings 
were carried out at room temperature (20–22°C). Voltage protocols 
are described in the figure legends.
Drugs were applied to the cells using a gravity-driven per-
fusion system. 2-arachidonylglycerol (2-AG) was purchased from 
Tocris Bioscience, Inc. (Ellisville, MO, USA), and dissolved to a 
stock concentration of 10 mM in dimethyl sulfoxide. For experi-
ments using 2-AG, fatty acid-free bovine serum albumin (0.5 mg/
ml) was added to all external solutions. Norepinephrine (NE) 
bitartrate salt (Sigma-Aldrich, St. Louis, MO, USA) was dissolved 
in H
2
O to a stock concentration of 10 mM. All drugs were diluted 
to their final concentrations in external solution just prior to 
the experiment.
data analysIs and statIstIcs
Data were analyzed using IgorPro 6.0 (WaveMetrics, Lake Oswego, 
OR, USA) and Prism 5.0 (GraphPad Software, San Diego, CA, 
USA). Where possible, the distribution of data was assessed using 
D’Agostino and Pearson omnibus normality test. Normally dis-
tributed data were expressed as the mean ± s.e.m., and statistical 
comparisons were made using unpaired Student’s t-test. Non-
Gaussian data were expressed as the median and the interquar-
tile range (IQR), and statistical comparisons were made using the 
Mann–Whitney non-parametric test. P values <0.05 were consid-
ered significant.
results
oPtIMIzatIon of mrna transfectIon condItIons for 
dIssocIated drg neurons
Cationic lipid-mediated transfection of plasmid DNA results in 
very poor levels of heterologous expression in adult dissociated 
DRG neurons (see Supplementary Material and Figure S1) and 
therefore a simple alternative method of heterologous expression 
would be highly desirable. As described in the introduction, cationic 
lipid transfection of mRNA has potential advantages for heterolo-
gous expression in non-dividing cells. For this reason a series of 
experiments were undertaken to establish the optimal conditions 
for mRNA transfection of dissociated DRG neurons. This prepa-
ration provided a sufficient quantity of neurons (with a minimal 
amount of glial cells) for a “high-throughput” 96-well plate-based 
lucIferase assay
Twenty-four hours after plating, cells were washed twice with PBS 
before being transfected in triplicate using the transfection con-
ditions described in the section “Results.” Prior to lysis, neurons 
were washed twice with PBS. 80 μl of M-Per lysis buffer (Thermo 
Scientific, Rockford, IL, USA) was added to each well and thor-
oughly mixed using a multichannel pipette. After 15 min incu-
bation at room temperature, the lysate was diluted fivefold in 
PBS, and the luciferase activity of 10 μl of the diluted lysate was 
assayed using 100 μl of 5 μM benzyl-coelenterazine (NanoLight 
Technology, Pinetop, AZ, USA) or Dual Luciferase Reporter Assay 
System (Promega) in an LB 960 microplate luminometer (Berthold 
Technologies, Oak Ridge, TN, USA). Luciferase activity was nor-
malized to a control transfection condition or to the transfection 
condition that leads to maximum activity, as indicated in the 
section “Results.”
IMagIng
Transfection efficiency calculations were carried out using images 
acquired on a TE2000-U microscope equipped with a Plan Fluor 
10× (0.3 NA) objective, GFP filter cube (all Nikon Instruments, 
Melville, NY, USA), a 12-bit Orca-ER CCD camera (Hamamatsu, 
Bridgewater, NJ, USA), and an X-Cite series 120Q mercury arc 
lamp (EXFO, Mississauga, ON, Canada). Transfection efficiency 
was calculated using a phase contrast cell image and epifluores-
cence image, acquired using a 2 s exposure, of the same field. 
The neurons were identified and counted manually from the 
phase contrast image using the ImageJ program (NIH, http://
rsb.info.nih.gov/ij) and the “Cell Counter” plug-in. Transfected 
cells were identified from the fluorescence image. Approximate 
neuron-sized regions of the fluorescence image with intensities 
above the background of untransfected neurons were identified 
using the particle analysis algorithm of ImageJ. The minimum 
intensity threshold was calculated from the intensities of fluo-
rescence images measured from untransfected neurons, and a 
minimum particle area of 21 μm2 was used. A mask of regions 
of high fluorescence (created by the particle analysis algorithm) 
was overlaid onto the phase image (see Figure 1Biii), and neurons 
that were both identified in the initial total neuron count and cov-
ered by the mask were designated as transfected. The transfection 
efficiency was calculated by dividing the number of transfected 
neurons by the total number of neurons in the phase image. For 
each dish, the mean transfection efficiency was calculated from 
images from four fields of view. At least two dishes were imaged 
per experiment. For clarity, linear adjustment of the contrast of 
the fluorescence images presented in the figures has been made. 
The same contrast adjustment was applied to both control and 
experimental images.
electroPhysIologIcal recordIng
Currents were recorded using conventional whole-cell patch clamp 
techniques. Recordings were obtained using an Axopatch 200B 
amplifier (Molecular Devices, Sunnyvale, CA, USA). Patch pipettes 
were fabricated from Corning 8250 borosilicate glass capillaries 
(King Precision Glass, Claremont, CA, USA) using a P-97 Flaming-
Brown micropipette puller (Sutter Instruments, Novato, CA, USA). 
Pipettes were coated with Sylgard (Dow-Corning, Midland, MI, 
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control cells, while a range of GFP expression is clearly visible in 
the transfected cells (Figure 1Bii). The transfection efficiency was 
quantified using a mask of the fluorescence image overlaid onto the 
phase image (Figure 1Biii; see Methods for details). 26 ± 3% (n = 8) 
of DRG neurons expressed levels of GFP detectable by this method. 
A high threshold was chosen so that autofluorescence from DRG 
neurons did not complicate the transfection efficiency measure-
ments. For this reason, neurons expressing very low levels of GFP 
were not considered “transfected” in our calculations.
oPtIMIzatIon of the mrna vector
It would be advantageous to maximize the level of protein expres-
sion from mRNA. The untranslated regions (UTRs) of mRNA are 
important for controlling levels of protein expression by influencing 
mRNA stability and translation efficiency (Pesole et al., 2001). For 
this reason, the effect of replacing the UTR of our Rluc mRNA with 
UTRs that have previously been shown to increase heterologous 
protein was investigated. Experiments were carried out using DRG 
neurons in a 96-well luciferase-based assay format, as described 
above. Neurons were transfected with 30, 100, or 300 ng of mRNA 
transcribed from templates containing the same Rluc sequence but 
with variations to the 5′-UTR or 3′-UTR (Figure 2Ai). The luci-
ferase activity was normalized to the activity in lysates transfected 
with 100 ng of control Rluc mRNA (Figure 2Aii). A plasmid vec-
tor, pRNA2-(A)
128
, was constructed which contained a 128-base 
polyadenine [poly(a)] tract on the 3′-UTR (see Supplementary 
Material). Transcription using a pRNA2-(A)
128
 template yielded a 
mRNA with a fixed length of poly(a) tail, which did not require 
the enzymatic polyadenylation step which can lead to variable 
lengths of the poly(a) tail (Holtkamp et al., 2006; see Figure S2 in 
Supplementary Material). In cells in transfected with 100 ng Rluc 
mRNA containing the (A)
128
 tail, luciferase activity was 144 ± 4% 
(n = 3) of the control mRNA construct. Removal of the poly(a) tail 
led to a substantial reduction to 0.5 ± 0.1% (n = 3) of control luci-
ferase activity, which demonstrates the importance of the poly(a) 
tract for efficient protein expression from mRNA.
The mRNA vector used in the current study contains a tandem 
repeat of two human β-globin 3′-UTR sequences, which has been 
shown to increase protein expression in dendritic cells (Holtkamp 
et al., 2006). Luciferase activity in neurons transfected with 100 ng 
of mRNA lacking the β-globin sequences (∆β-globin; Figure 2Ai) 
was 44 ± 1% of luciferase activity of neurons transfected with 
100 ng of the control construct (n = 3; Figure 3Aii). Interpretation 
of this modest change in Rluc activity is difficult. As described 
in the section “Results” in Supplementary Material (Figure S3 in 
Supplementary Material), transfection of different preparations 
of Rluc mRNA transcribed from the same template can result in a 
range of luciferase activities. Therefore, it is difficult to determine 
whether changes in luciferase activity arise from changes to pro-
tein expression as a result of alterations to the mRNA sequence or 
because of variability between mRNA preparations.
The 5′-UTR sequence of the mRNA is an important determinant 
of translational efficiency (Pain, 1996). In an attempt to maxi-
mize protein expression from the mRNA, the 5′-UTR sequence of 
our mRNA was replaced with 5′-UTRs that have previously been 
demonstrated to confer high translational efficiency to the coding 
assay. Neurons were transfected with Rluc mRNA and luciferase 
expression was quantified from cell lysates using a luminescence-
based luciferase activity assay.
First, experiments were carried out to determine the optimum 
amount of mRNA for transfection. In these experiments, a constant 
volume of L2K (0.24 μl) was used and the amount of Rluc mRNA 
was varied between 50 and 1000 ng per transfection. DRG neurons 
were incubated in the presence of the transfection mix for 1 h. The 
maximum expression of luciferase occurred at around 500 ng of 
Rluc mRNA and reached a plateau (Figure 1Ai). Transfection of 
100 ng of Rluc mRNA resulted in 49 ± 7% (n = 4) of the maximum 
level of luciferase activity and was used in subsequent optimization 
experiments unless stated otherwise. This quantity of mRNA was 
chosen because it provided a large dynamic range for assessing luci-
ferase expression. In addition, when the quantity of mRNA is scaled 
up to that required for transfection in a 35 mm dish, preparation of 
quantities of mRNA equivalent to >100 ng becomes impractical. To 
establish the optimum amount of L2K to use per transfection, neu-
rons were transfected with 100 ng of Rluc mRNA and the amount 
of L2K was varied between 0.03 and 0.98 μl (Figure 1Aii). DRG 
neurons were incubated in the presence of the transfection mix for 
1 h. The maximum amount of luciferase activity occurred using a 
transfection mix containing between 0.12 and 0.24 μl of L2K, and 
decreased appreciably with larger volumes of L2K. The optimum 
duration of incubation with the transfection mix was ascertained 
by incubating the neurons for 0.25–6 h with a transfection mix 
containing 0.24 μl L2K and 100 ng of Rluc (Figure 1Aiii). The 
peak luciferase activity occurred with an incubation duration of 
approximately 1 h. The time course of luciferase expression was 
determined by incubating neurons with a transfection mix contain-
ing 0.24 μl L2K and 100 ng of Rluc for 1 h, lysing the neurons and 
measuring luciferase activity at time-points between 0.5 and 72 h 
after transfection. As shown in Figure 1Aiv, the luciferase activity 
reached a peak 12–16 h after transfection.
To investigate the potential for a different combination of Rluc 
mRNA mass and L2K volume to provide a higher level of Rluc 
expression, neurons were transfected with transfection mix con-
taining 50–1000 ng Rluc mRNA and either 0.08, 0.24, or 0.75 μl 
L2K. Cells were incubated with the transfection mix for 1 h and 
Rluc activity was measured 16 h after transfection. As shown in 
Figure 1Av, the maximum Rluc activity increased as the volume of 
L2K increased, but in transfections using less than 250 ng of Rluc 
mRNA, luciferase activity was lower using 0.74 μl than with either 
0.24 μl or 0.08 μl of L2K per transfection.
transfectIon effIcIency
Once the optimum transfection conditions were determined by 
the luciferase-based assay, transfection efficiency was calculated 
using an imaging-based method to quantify the proportion of DRG 
neurons that express (green fluorescent protein) GFP following 
transfection with GFP mRNA. DRG neurons were plated in 35 mm 
dishes and the quantities of the transfection reagents were scaled 
up to the appropriate volume: 3.1 μg of GFP mRNA, 3.75 μl L2K in 
a 2 ml volume. Neurons were incubated with the transfection mix 
for 1 h and the cells were imaged 16 h after transfection. As shown 
in Figure 1Bi, minimal fluorescence is visible in the untransfected 
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Figure 1 | Optimization of mrNA transfection in dissociated Drg 
neurons. (A) Rluc mRNA transfection of DRG neurons using different 
transfection conditions was assessed by a luciferase assay of cell lysates. 
Unless indicated, the transfection mix contained 0.24 μl L2K and 100 ng Rluc 
mRNA. Neurons were incubated with the transfection mix for 1 h and luciferase 
activity was measured 16 h after transfection. Except for (vi), data were 
normalized to the condition within the experiment with the maximum luciferase 
activity. (i) Transfection mix containing 0–1000 ng of Rluc mRNA (n = 4) (ii) 
Transfection mix containing 0–1.0 μl of L2K (n = 8). (iii) Neurons incubated with 
transfection mix for a duration of 0–6 h (n = 4). (iv) Time course of luciferase 
activity following transfection. Luciferase activity was measured between 0 and 
72 h following transfection (n = 4). (v) Luciferase expression using a 
transfection mix containing 30–1000 ng Rluc mRNA and 0.08 μl (n), 0.24 μl (l), 
or 0.73 μl (¡) L2K (n = 3). (vi) Transfection mix containing 100 ng of Rluc mRNA 
and 1–300 ng of Fluc mRNA (l) or yeast tRNA (¡). Data was normalized to the 
luciferase activity of cell lysates transfected with 100 ng Rluc mRNA alone 
(n = 3). The points on the graphs represent the mean luciferase activity ± s.e.m. 
(B) Transfection efficiency of DRG neurons. (i) Phase and fluorescence image 
of untransfected DRG neurons. (ii) Phase and fluorescence image of DRG 
neurons transfected with 3.1 μg GFP mRNA, 16 h after transfection (iii) Phase 
image with overlay of a mask created from the fluorescence image. The mask 
indicates regions of the image with fluorescence intensities over a threshold 
above which neurons were classified as transfected (see Methods). 100 μm 
scale bar (for all images).
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mRNA to which they are attached. So far, the 5′-UTR of the mRNA 
used in this study consists of the multiple cloning region of the 
cDNA plasmid template. This “control” 5′-UTR was replaced with 
5′-UTRs from tobacco mosaic virus (TMV; Gallie et al., 1987a), 
alfalfa mosaic virus (AMV; Jobling and Gehrke, 1987), wild type 
rabbit α-globin, or a chimeric α-globin containing a region of 
β-globin 5′-UTR sequence (Kozak, 1994). Rluc activity of lysates 
from DRG neurons transfected with 30, 100, or 300 ng of the Rluc 
mRNA containing the alternative 5′-UTRs was normalized to the 
luciferase activity of lysates transfected with 100 ng of the control 
luciferase mRNA (Figure 2B). The Rluc activity of neurons trans-
fected with 100 ng of TMV 5′-UTR mRNA was 138 ± 4% (n = 3) 
of control Rluc activity. In neurons transfected with 100 ng of the 
AMV 5′-UTR, the luciferase activity was 51 ± 2% of the control 
construct. Rluc activity from neurons transfected with 100 ng of 
wild type or chimeric α-globin 5′-UTR were 32 ± 2% (n = 3) and 
28 ± 3% (n = 3) of the control Rluc construct, respectively. These 
result suggest that replacement of the control 5′-UTR was unable 
to produce a substantial increase in Rluc expression.
transfectIon of dIssocIated scg neurons
The ability to heterologously express proteins in neurons and carry 
out electrophysiological recordings is a valuable technique for neu-
roscience research. In our hands, reliable whole-cell patch clamp 
recordings of Ca2+ currents in SCG neurons using a method other 
than intranuclear microinjection for acute heterologous expres-
sion is difficult. To determine the suitability of mRNA transfec-
tion for patch clamp experiments, SCG neurons were transfected 
Figure 2 | Optimization of mrNA uTrs for maximum protein expression. 
The effect of changes to the Rluc mRNA UTRs on expression of Rluc was 
investigated using a luciferase activity assay. (A) (i) a schematic of modifications to 
the 3′-UTR of Rluc mRNA. (ii) Graph showing luciferase activity of lysates from 
DRG neurons transfected with 30, 100, and 300 ng of control Rluc mRNA (l), Rluc 
mRNA containing vector poly(a) sequence (vector poly(a); n), Rluc mRNA without 
β-globin sequences (∆ β-globin; ¨ ), or Rluc mRNA lacking a poly(a) sequence (∆ 
poly(a); ¡). Data were normalized to luciferase activity of neurons transfected with 
100 ng of control Rluc mRNA (n = 3). (B) Graph of luciferase activity of cell lysates 
from DRG neurons transfected with 30, 100, 300 ng of control Rluc mRNA (l) or 
with the control 5′-UTR replaced with the 5′-UTR from tobacco mosaic virus (TMV; 
), alfalfa mosaic virus (AMV; ), rabbit wild type α-globin (n), or rabbit chimeric 
α-globin ( )¨. Data were normalized to the luciferase activity of neurons 
transfected with 100 ng of control Rluc mRNA (n = 3).
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Figure 3 | gFP expression in rat SCg neurons using a suspension-based 
mrNA transfection technique. (A) (i) Phase and fluorescence image of 
untransfected SCG neurons. (ii) Phase and fluorescence image of SCG neurons 
transfected with 3.1 μg GFP mRNA, 16 h after transfection. 100 μm scale bar. 
(B) Representative Ca2+ currents recorded from control SCG neurons (i) and 
neurons transfected with 3.1 μg GFP mRNA (ii). Currents were evoked using 
the voltage protocol shown in (i). Control currents are shown in black, and 
currents in the presence of 10 μM NE are shown in red.
with GFP mRNA and endogenous Ca2+ currents were monitored 
using whole-cell patch recording. In preliminary experiments, in 
which the SCG were plated up to 6 h prior to transfection, the 
majority of neurons detached from the dish when the transfec-
tion mix was replaced with culture media. Reliable Ca2+ current 
recording from the remaining cells was problematic: GΩ seals 
were difficult to achieve, neurons were “leaky” (i.e., had low input 
resistance), and Ca2+ currents were smaller than in untransfected 
neurons (results not shown). A modified method of transfection 
was developed in which cells were transfected in suspension (see 
Methods). Using this technique, the neurons adhered well to the 
dish and GFP was expressed in neurons (Figure 3A) with similar 
efficiency to the DRG neuron experiments described above. Ca2+ 
currents were evoked by a double-pulse protocol consisting of two 
test pulses (“prepulse” and “postpulse”) to +10 mV separated by 
a large depolarizing conditioning pulse to +80 mV (Elmslie et al., 
1990; Figure 3B). A comparison of the amplitude of the prepulse 
Ca2+ current, the current density, and the basal facilitation of Ca2+ 
currents (the ratio of the postpulse to prepulse current amplitude 
in the absence of agonist), which has been shown to arise from a 
small amount of tonic G protein activation (Ikeda, 1991), shows 
there are no significant differences between GFP-transfected 
and untransfected neurons (Table 1). Application of 10 μM NE 
produced a voltage-dependent  inhibition of Ca2+  currents that 
was similar in both GFP-transfected and untransfected neurons 
(Figure 3B and Table 1). The increase in the facilitation ratio 
during agonist application is characteristic of the G protein 
βγ-subunit-mediated inhibition of Ca2+ current that follows NE 
activation of α
2
-adrenoceptors (Herlitze et al., 1996; Ikeda, 1996). 
The similarity between the transfected and untransfected cells 
indicates that GFP transfection has little effect on endogenous 
Ca2+ currents and the modulation of Ca2+ currents that follows 
α
2
-adrenoceptor activation.
functIonal heterologous recePtor, channel and doMInant-
negatIve exPressIon froM mrna
The GFP transfection experiments suggest that mRNA transfection 
does not cause substantial changes to SCG neuron signaling and 
health. To determine if functional receptors could be expressed and 
couple to endogenous signaling pathways, neurons were cotrans-
fected with 3.1 μg of each of the mRNAs encoding the transcript 
variant 1 of human CB1R and EGFP (as a marker to identify suc-
cessfully transfected neurons). Ca2+ currents were evoked using the 
double-pulse protocol described above. In control neurons, in the 
presence of 10 μM of the CB1R agonist 2-AG, the mean change in 
amplitude of the prepulse current was 0 ± 1% (n = 17) of the  current 
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SCG neurons (Ikeda, 1996). Neurons were  cotransfected with 3.1 μg 
G
oA
 mRNA and 3.1 μg of GFP mRNA. Ca2+ currents were evoked 
using the double-pulse voltage protocol described earlier. As shown 
in Figure 4C, NE caused a median reduction of 54% (IQR 47–50%; 
n = 31) of prepulse Ca2+ current in untransfected neurons, whereas 
in neurons transfected with G
oA
 mRNA, the median reduction in 
Ca2+ current was 8% (IQR 3.5–14%; n = 33; P < 0.001). These results 
suggest that mRNA transfection can provide sufficient G
oA
 expres-
sion to act as a Gβγ sink, which reduces NE-mediated Ca2+ current 
inhibition in SCG neurons.
transfectIon of hIPPocaMPal and cortIcal 
neuronal cultures
Heterologous expression in cultures of central neurons using cati-
onic lipids and cDNA plasmid vectors is often of low efficiency 
(Washbourne and McAllister, 2002). In order to assess the suit-
ability of mRNA transfection for heterologous expression in central 
neurons, cultures of hippocampal and cortical neurons from P0 to 
P1 rats were transfected with 2 ml transfection mix contain 3.1 μg of 
GFP mRNA and 3.75 μl of L2K per dish. Cultures were incubated in 
the presence of the transfection mix for 1 h at 37°C. After removal 
of the transfection mix, cultures were washed twice with PBS, the 
culture media was replaced and the cell incubated for approximately 
16 h before imaging. As shown in Figure 5, a variety of cell types 
could be transfected and, judging by the gross morphology of the 
cells, transfection was not substantially toxic.
dIscussIon
This study has shown that mRNA-cationic lipid complexes can 
be used as an efficient method for heterologous protein expres-
sion in a variety of neurons. mRNA transfection is well suited for 
acute expression of proteins for patch clamp recording experi-
ments – a technique which is particularly difficult using other 
heterologous protein expression methods because of toxicity or 
the extended period of time in culture required for sufficient 
expression. The technique described is easy to perform and requires 
minimal equipment.
functIonal exPressIon of ProteIns at a hIgh  
transfectIon effIcIency
A transfection efficiency of 25% was measured in GFP-transfected 
DRG neurons. This figure is a conservative measurement because 
of the high threshold of fluorescence intensity by which success-
ful transfection was judged. A much higher transfection efficiency 
would likely be obtained using a more sensitive assay such as such 
as β-galactosidase activity. However, when assessing a method of 
heterologous expression, it is important to consider the transfection 
efficiency in relation to the level of heterologous protein expression. 
A sufficient proportion of the cells should express enough protein 
to generate the phenotype under investigation so that one can be 
confident that the cells chosen for further study (electrophysiologi-
cal recording, imaging, etc) are a good representation of the popula-
tion of the cells under investigation. While the levels of expression 
obtained using the mRNA transfection method described here are 
substantially lower than levels of expression that typically result 
from intranuclear microinjection of cDNA, there sufficient expres-
sion to generate a clear phenotype for all the transgenes chosen 
of in the absence of 2-AG (Figure 4A). In neurons transfected 
with CB1R and EGFP, the mean amplitude of the prepulse current 
during application of 2-AG was 51 ± 3% of the control amplitude 
(n = 18; P < 0.001). The inhibition displayed the hallmarks of Gβγ-
mediated inhibition (described above) and is consistent with previ-
ous studies using intranuclear microinjection of cDNA to express 
CB1R in SCG neurons (Guo and Ikeda, 2004).
To determine if functional ion channels could be expressed from 
mRNA in SCG neurons, neurons were cotransfected with 3.1 μg 
mRNA encoding the GIRK4 S143T mutant subunit and 3.1 μg of 
GFP mRNA. A GIRK channel was chosen because of the lack of 
native expression of GIRK subunits in SCG neurons (Ruiz-Velasco 
and Ikeda, 1998). GIRK currents were evoked by a 200 ms voltage 
ramp from −140 to −40 mV from a holding potential of −60 mV 
following activation of endogenous α
2
-adrenoceptors by 10 μM 
NE. In GFP-positive cells, NE elicited a clear inwardly rectifying 
current that was not present in untransfected cells (Figure 4Bi). The 
amplitude of the current was measured at 40 ms after the start of 
the ramp protocol (corresponding to a potential of approximately 
−120 mV) in the presence of 10 μM NE. In the GFP-positive cells, 
the median amplitude of the current was 670 pA (IQR: −270 to 
−2500 pA; n = 28) and in untransfected control cells, the median 
amplitude was 150 pA (IQR −10 to −210 pA; n = 13; P = 0.001; 
Figure 4Bii). These results demonstrate mRNA transfection is suit-
able for heterologous expression of channels that can couple to 
endogenous signaling pathways.
Heterologous expression of a “dominant-negative” protein pro-
vides a useful method to investigate the function of a specific protein 
(Herskowitz, 1987). This method often requires substantial levels 
of expression for a phenotype to become apparent. To determine 
whether sufficient expression can be achieved using mRNA trans-
fection for a dominant-negative experiment, SCG neurons were 
transfected with mRNA encoding a G
oA
 mutant. Intranuclear micro-
injection of a similar G
oA
 mutant cDNA plasmid has previously been 
demonstrated to abolish the NE-mediated Ca2+ current inhibition in 
Table 1 | The effect of gFP mrNA transfection on Ca2+ currents and 
Ne-mediated Ca2+ current inhibition in SCg neurons. Characteristics of 
endogenous Ca2+ currents were measured in untransfected SCG neurons 
and neurons transfected with 3.1 μg of GFP. Facilitation was calculated from 
the ratio of postpulse Ca2+-current amplitude to the prepulse current 
amplitude.
Measurement untransfected gFP-transfected P-value
 neurons (n = 18) neurons (n = 22) (unpaired
   t-test)
ICa amplitude (nA) −1.8 ± 0.2 −1.6 ± 0.2 0.29
Capacitance (pF) 64 ± 4 65 ± 5 0.85
Current density 30 ± 2 25 ± 2 0.12
(pA/pF)
Basal facilitation 1.5 ± 0.0 1.4 ± 0.1 0.49
Percent inhibition 59 ± 2 61 ± 2 0.54
of ICa in the
presence of NE
Facilitation in the 2.7 ± 0.1 2.8 ± 0.1 0.33
presence of NE
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Figure 4 | Functional heterologous expression of a receptor, channel, and 
dominant-negative goA using mrNA transfection in SCg neurons. (A) 
2-AG-mediated Ca2+ current inhibition in SCG neurons transfected with 3.1 μg 
CB1R mRNA. (i) Superimposed traces of Ca2+ currents in the absence (black) 
and presence of 10 μM 2-AG (red) in control neurons (left) and neurons 
transfected with CB1R mRNA (right). Currents were evoked using the voltage 
protocol shown. (ii) Scatter plot showing the inhibition of Ca2+ current by 2-AG in 
untransfected neurons (¡) or neurons transfected with CB1R mRNA (l). % 
Inhibition was calculated from the amplitude of the prepulse current before and 
in the presence of 2-AG. Each data point represents a recording from a different 
neuron. The red line represents the mean value. ***Represents a P < 0.001, 
unpaired t-test. (B) NE-mediated GIRK currents in SCG neurons transfected with 
3.1 μg GIRK4 S143T mRNA. (i) Superimposed traces of currents in the absence 
(black) and presence of 10 μM NE (red) in control neurons (left) and neurons 
transfected with GIRK4 mRNA (right). Currents were evoked using the voltage 
protocol shown. (ii) Scatter plot showing GIRK current by elicited by NE in 
untransfected neurons (¡) or neurons transfected with GIRK4 mRNA (l). GIRK 
current was measured 40 ms after the start of the voltage ramp. Each data point 
represents a measurement from a different neuron. The red line represents the 
median value. ***Represents a P = 0.001, Mann–Whitney test. (C) Reduction of 
NE-mediated Ca2+ current inhibition in SCG neurons transfected with 3.1 μg GoA 
G203T. (i) Superimposed traces of Ca2+ currents in the absence (black) and 
presence of 10 μM NE (red) in control neurons (left) and neurons transfected 
with GoA mRNA (right). Currents were evoked using the voltage protocol shown. 
(ii) Scatter plot showing inhibition of Ca2+ current by 10 μM NE in untransfected 
neurons (¡) or neurons transfected with GoA mRNA (l). % Inhibition was 
calculated from the amplitudes of the prepulse current before and in the 
presence of NE. Each data point represents a recording from different neuron. 
The red line represents the median value. ***Represents a P < 0.001, 
Mann–Whitney test.
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(Fluc) to the transfection mix was shown to have little effect on 
expression of the Rluc mRNA (Figure 1Avi). Reduced expression 
of Rluc is only apparent at when the transfection mix contained 
large amounts of Fluc mRNA. A similar reduction in Rluc expres-
sion also occurs when large amounts of untranslated RNA (tRNA) 
is added to the transfection mix, which suggests that there might 
be competition between the two RNA species for L2K to form 
L2K-RNA complexes.
There are likely to be drawbacks in simply using more mRNA/
L2K as an approach to increasing the expression of a heterologous 
protein. In addition to the inconvenience and high cost of pre-
paring large amounts of mRNA, increased exposure of neurons 
to L2K may be unfavorable. In experiments where neurons were 
exposure to high levels of L2K (Figures 1Aii, Av for quantities of 
mRNA <250 ng) or a long period of exposure to L2K was used 
(Figure 1Aiii), there was a decrease in luciferase activity. This reduc-
tion is consistent with previous studies showing that some cationic 
lipids are associated with toxicity (Farhood et al., 1992; Lappalainen 
et al., 1994; Jacobsen et al., 2009), and suggests that the amount of 
L2K should be kept as low as possible.
in this study (Figure 3). This functional data is a good indication 
that mRNA transfection is suitable for functional expression of a 
variety of proteins at a high transfection efficiency.
PotentIal for exPressIon of hIgh levels of  
heterologous ProteIns
Inhibition of Ca2+ current by overexpression of Gα subunits is 
assumed to require a relatively high level of expression (Ikeda, 
2004), and based on the inhibition of Ca2+ currents in the G
oA
 
overexpression experiment (Figure 4C), the levels of expression 
is likely to be suitable for most studies. If higher levels of expres-
sion are required, it may be possible to increase the amount of 
heterologous protein by increasing the amount of L2K and RNA. 
As shown in Figure 1Av, the level at which Rluc expression reached 
a plateau increased as the volume of L2K increased. These results 
suggest that the plateau in mRNA expression that occurs at higher 
RNA quantities (see also Figure 1Ai) is likely to be caused by a 
limiting amount of L2K, rather than saturation of the translation 
machinery. The hypothesis is supported by the experiments in 
which addition of increasing amounts of a second coding mRNA 
Figure 5 | mrNA transfection of hippocampal and cortical neuron cultures. 
(A) Cultured, dissociated hippocampal neurons transfected with 3.1 μg GFP mRNA. 
(i) wide-field phase and fluorescence images. (ii) Enlarged detail of the same 
images. The red arrow indicates the same transfected neuron in both images. 
(B) Cultured dissociated cortical neurons. (i) Wide-field phase and fluorescence 
images. (ii) Enlarged detail of the same images. The red arrow indicates the same 
transfected cell in the wide-field and enlarged images. Phase and fluorescence 
images were acquired from the same field of view. 50 μm scale bar in all images.
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Previous studies have shown that enzymatic polyadenylation 
is variable and that changes to length of the poly(a) tail results 
in changes to mRNA stability and/or protein expression (Elango 
et al., 2005; Holtkamp et al., 2006). It is possible that the vari-
ability of enzymatic polyadenylation was the cause of the vari-
ability in transcript size (Figure S3ii in Supplementary Material) 
and protein expression (Figure S3iii in Supplementary Material) 
that occurred between different mRNAs transcribed from the 
same template. Transcription from a template containing a poly(a) 
sequence is likely to give a fixed length of poly(a) tail (Holtkamp 
et al., 2006). Given that the level of protein expression was adequate 
from both enzymatically polyadenylated mRNA or mRNA tran-
scribed from pRNA2-(a)
128
 (Figure 2A), the template poly(a) may 
provide a method to avoid the variability in protein expression 
that occurs when enzymatically polyadenylated mRNA are used 
in transfections.
There are a number of sequences in the UTRs that affect mRNA 
stability (Ross, 1995). The majority of these sequences are destabi-
lizing which reduce protein expression. Of the few sequences that 
increase mRNA stability, most are binding sites for proteins that 
prevent the access of an endonuclease to a specific target sequence 
(Chen et al., 2000; Tebo et al., 2000; Wang and Kiledjian, 2000) 
rather than stabilizing the mRNA per se. One of the few sequences to 
actively promote mRNA stability is the β-globin 3′-UTR. The stabi-
lizing effect is mediated by the binding of a multisubunit complex to 
a sequence in the 3′-UTR which protects the tail from deadenylation 
and subsequent breakdown of the mRNA (Yu and Russell, 2001; 
Jiang et al., 2006). The addition of β-globin UTR to mRNA is a com-
monly used approach to maximize protein expression from in vitro 
transcribed mRNA; for example, addition of β-globin UTRs to Rluc 
mRNA has been shown to increase protein expression by ninefold 
in NIH/3T3 cells (Malone et al., 1989), and the addition of tandem 
β-globin 3′-UTRs to GFP mRNA leads to a twofold increase in GFP 
expression in dendritic cells (Holtkamp et al., 2006). In the current 
study, the control mRNA in the study contained a tandem repeat 
of the human β-globin 3′-UTR. Removal of the tandem sequence 
caused a 50% decrease in expression (Figure 2A). The cause of 
this reduction is difficult to determine; in addition to a reduction 
in mRNA stability and variations between mRNA preparations, 
removal of the 3′-UTR can decrease translation efficiency. Previous 
studies have showed that reducing the 3′-UTR from 27 to 7 bases 
(not including the poly(a) tail) causes a decrease in translation effi-
ciency that results in a 35-fold reduction in protein expression from 
exogenous mRNA in CHO cells. In the current study, the 3′-UTR of 
the mRNA lacking the β-globin repeat is only 12 bases long, which 
is likely to have a substantial effect on translation efficiency.
MaxIMIzIng translatIon effIcIency
Translation efficiency is mostly influenced by sequences in the 5′-UTR 
(Wilkie et al., 2003). Much like for mRNA stability, the majority of 
the identified sequences that influence translation efficiency reduce 
protein expression. These sequences form stable secondary structures 
or providing binding sites for regulatory proteins, which prevent 
movement of the translation machinery along the mRNA. Efficient 
translation appears to be dependent on the 5′-UTR being without sig-
nificant secondary structure and of sufficient length (over 20 bases), 
rather than the presence of specific sequences (Kozak, 1991b).
Preliminary experiments to assess the toxicity of mRNA 
 transfection were carried out using a modified “MTT” assay 
(Denizot and Lang, 1986) (results not shown). Unfortunately, 
because of the relatively low number of cells used in our experi-
ments, the assay was found to be too insensitive to be of much 
practical use. It is likely that treatment of cells with cationic lipids 
will result in a number of changes to the cell (Jacobsen et al., 2009) 
and appropriate control experiments should be run. However, in 
our experience, the ability to obtain robust whole-cell patch clamp 
recording from SCG neurons is very sensitive to cell health and, as 
shown in Table 1, recordings obtained from transfected neurons 
were not significantly different to untransfected neurons. These 
result suggest that mRNA transfection is a relatively gentle method 
of heterologous expression, and toxic effects are minimal.
MaxIMIzIng exPressIon froM mrna
Because of the disadvantages of increasing the amount of mRNA 
and L2K, alternative approaches to increase protein expression 
were attempted. There are a number of steps in transfection that 
are potentially limiting to the level of protein expression. Previous 
studies show that once mRNA-cationic lipid complexes enter the 
cell, only a small proportion of the mRNA is released from the 
complexes and available to be translated (Bettinger et al., 2001; 
Barreau et al., 2006). Alternative transfection reagents have the 
potential to be more effective at delivering mRNA for transla-
tion, but preliminary experiments using PEI or Lipofectamine LTX 
reagents were unsuccessful. For this reason, optimization of the 
transcript to ensure maximum translation provides an approach 
with greater potential to increase protein expression. At the level 
of the transcript, the amount of expression is likely to be deter-
mined by the stability and the translation efficiency of mRNA 
(Ross, 1995; Wilkie et al., 2003). In this study, a number of modi-
fications were made to the UTRs of the mRNA transcript, which 
have previously been shown to increase the amount of protein 
expression from exogenous mRNA. In this investigation, many of 
changes caused by the modifications were fairly small (approxi-
mately ±50% of the control protein expression; Figure 2) and 
could be attributed to variability between mRNA preparations 
(Figure S3 in Supplementary Material). Only the reduction in 
expression that followed removal of the poly(a) sequence was of 
sufficient magnitude to be confident that it resulted from changes 
to the mRNA transcript.
oPtIMIzatIon of mrna stabIlIty
mRNAs are highly labile in the presence of ribonucleases that exist 
in the cytosol. The short half-life of mRNA and the resulting short 
window in which translation can occur is thought to be the cause 
of lower levels of protein expression when compared to expression 
from plasmid DNA (Wolff et al., 1990; Kariko et al., 1998; Bettinger 
and Read, 2001). The in vitro transcribed RNA transcript used in 
this study contains a poly(a) tail, a feature that is found in almost 
all mature eukaryotic mRNA transcripts. It is well established that 
the poly(a) tail is vital for stable mRNA (Marbaix et al., 1975) and 
is also required for protein translation (Sachs et al., 1997). The 
importance of the poly(a) tail was confirmed by the very large 
reduction luciferase expression from mRNA lacking a poly(a) 
tail (Figure 2A).
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be caused by the relative inefficiency of protein expression from 
the  control  construct rather than an “active” enhancement. The 
control construct described in the aforementioned studies is short 
(17 bases), which may reduce translation efficiency (Kozak, 1991a). 
Replacement of this sequence with the TMV 5′-UTR, which is long 
(41 bases), free from destabilizing sequences and significant sec-
ondary structure (∆G = −5 kcal/mol), is likely to cause an increase 
in expression. The similarity between the TMV and the control 
5′-UTR used in the current study means that they are likely to 
influence translation to a similar degree, which is supported by the 
similar levels of protein expression obtained (Figure 2B).
Our results indicate suggest that there is limited potential to 
increase protein expression from our mRNA transcript by chang-
ing the UTR sequences. If high levels of heterologous protein are 
required, other approaches are necessary; for example, transfec-
tion of a self-replicating mRNA transcript has been shown to 
increase heterologous expression in cell lines (Johanning et al., 
1995). Alternatively, delivery of “naked” mRNA has the potential 
to increase heterologous expression because the mRNA does not 
have to be released from a mRNA-cationic lipid complex before 
translation. It is possible that development of the “nucleofection” 
electroporation technique (Teruel et al., 1999) could provide an 
effective method for delivery of naked mRNA into neurons. Since 
mRNA only has to enter to the cytosol, less aggressive electropora-
tion parameters than those used for cDNA plasmids are likely to 
be required. This more gentle process may be less detrimental to 
neuron health than cDNA plasmid electroporation.
aPPlIcatIons of neuronal mrna transfectIon
As shown in this study, mRNA transfection is particularly well 
suited for single-cell assays such as voltage-clamp recording. In 
addition, the ability to express a genetically-encoded probe at high 
efficiencies could be particularly useful for identification of neuro-
nal subtypes in cultures containing a mixed population. This tech-
nique also enables experiments that have previously been confined 
to cell lines to be carried out in neurons; for example; heterologous 
expression in neurons to be can be applied to “high-throughput”-
style experiments and biochemical studies. These examples and the 
current study demonstrate that this technique has great potential 
and utility in many areas of neuroscience research.
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In this study, four different 5′-UTRs that have previously been 
shown to enhance protein expression were tested: AMV, TMV, wild 
type α-globin, and a chimeric α-globin that contains a region of 
β-globin sequence. The unstructured sequences of the AMV and 
two α-globin 5′-UTRs are thought to enhance translation by a lack 
of secondary structure mechanism described above (Gehrke et al., 
1983; Kozak, 1994). Previously, replacement of the control 5′-UTR 
sequence with the α-globin 5′-UTR sequences has been shown 
to increase expression in vitro and in cells approximately twofold 
(Kozak, 1994; Babendure et al., 2006). Exchanging a control 5′-UTR 
with the AMV 5′-UTR increases protein expression up to 35-fold 
in in vitro transcription systems (Jobling and Gehrke, 1987) and 
between two- and eightfold in cells, depending on the cell type (Gallie 
et al., 1987b). The TMV sequence represent one of the few 5′-UTR 
that actively enhances translation. In protoplasts, enhancement is 
dependent on binding of heat shock protein 101 to the 5′-UTR and 
involves the recruitment of the translation initiation factor eIF4F to 
the 5′ cap (Wells et al., 1998; Gallie, 2002). In plant cells the addition 
of a TMV 5′-UTR sequence has been shown to increase expression 
up to 30-fold (Gallie et al., 1987a) and increase two- to fourfold in 
mammalian cells (Gallie and Walbot, 1990; Gallie et al., 1991).
In this study, the different 5′-UTRs did not increase heterolo-
gous protein expression in comparison with the control construct. 
Perhaps, this absence of effect is to be expected: the increase in 
protein expression is dependent on the control construct, and the 
5′-UTR of control construct used in this study may already con-
tain the characteristics which confer optimal protein expression. 
For example, analysis of the thermodynamic stability of second-
ary structures in the control 5′-UTR (∆G = −22 kcal/mol; Zuker, 
2003) indicate that the sequence is unlikely to form a highly stable 
secondary structure. Any potential secondary structure formed is 
unlikely to be stable or in a position to substantially reduce transla-
tion efficiency (Kozak, 1986; Babendure et al., 2006). In addition, 
the control 5′-UTR is free from destabilizing sequences and suf-
ficiently long (90 bases) to confer high efficiency translation, both 
of which lead to a high level of protein expression.
The 5′-UTR of TMV did not cause a substantial increase in 
protein expression. The large difference in enhancement of pro-
tein expression between plant cells and other cell types has lead to 
the hypothesis that different mechanisms of enhancement exist 
(Gallie et al., 1991). A search of mammalian genes reveals no 
HSP101 gene or obvious homolog, which suggests that mamma-
lian cells do not possess the machinery required for the substantial 
enhancement of translation that occurs in plant cells. The increase 
in expression that has been demonstrated in previous studies may 
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3′ recesses were filled using the Klenow fragment. The parental 
 vector was then cut with HindIII to remove the coding sequence. 
The sequence was inserted into pRNA2 which had been cut with 
NotI, the overhangs filled, and cut with HindIII.
pRNA2-hRluc-∆β-globin. The β-globin sequences were removed 
from pRNA2 using a modification (Geiser et al., 2001) of the 
QuickChange mutagenesis system (Stratagene, La Jolla, CA, USA) 
with the following primers (only forward primer shown).
Forward: 5′-GTGCTGAAGAACGAGCAGTAAGCGGCCGCAT
TTAAATGTTTAAACAAACG-3′
(Not1 site is underlined (inserted for screening) Rluc stop codon 
in italics)
pRNA2-(A)
128
-Rluc. The initial approach to create pRNA2-(A)
128
 
was to simply insert a synthesized oligonucleotide duplex contain-
ing a 128 poly(A) sequence into appropriate restriction sites of the 
pRNA2, but there were difficulties in a obtaining a 128 poly(A) 
sequence from a commercial source. For this reason, an alterna-
tive method used. The following oligonucleotide containing the 
poly(T) was synthesized:
5′-GATATCACGAACGTACCCTCCCACCTGC-T(128)-
GTTTAAACCCTGCAGGCGCTTCGAGCAG-3′
(EcoRV and PmeI sites are underlined, primer binding region 
is in italics) A duplex of the oligonucleotide above was gener-
ated using standard PCR techniques and the following primer: 
5′-CTGCTCGAAGCGCCTGCAGGG-3′. The PCR product was 
cloned into PCR-Blunt II-Topo vector (Invitrogen) and sequenced. 
The TOPO-vector was digested with PmeI and EcoRV, for insertion 
into a PmeI-cut pRNA2 vector. Correct orientation of the poly(A) 
tract (with PmeI site upstream of the poly(A) tract) was confirmed 
by cutting the plasmid with PmeI and NotI. The Rluc sequence was 
removed from pRNA2-hRluc using HindIII and SwaI and inserted 
into the corresponding sites of pRNA2-(A)
128
.
For high levels protein expression, it is important that the 3′ end 
of the poly(A) tail contains only adenine nucleotides (Holtkamp 
et al., 2006). For a vector containing a poly(A) sequence, lineari-
zation by commonly used (Type II) restriction endonucleases, 
results in unwanted nucleotides remaining on the poly(A) tail. 
To prevent this problem, Type IIS restriction endonuclease sites 
were engineered into the sequence downstream of the poly(A) tail 
(Figure S4). As Type IIS restriction enzymes cleave at a site adjacent 
to the recognition sequence, these enzymes ensure that linearization 
of pRNA2-(A)
128
 results in an optimum poly(A) tail that is free of 
unwanted nucleotides.
Modified 5′-UTR pRNA2-Rluc constructs. The control 5′-UTR 
sequence of pRNA2-Rluc was replaced with the 5′-UTR described 
using QuickChange mutagenesis with the following primers 
(only forward primer shown; UTR underlined). Optimized 
a-globin:
5 ′-C-TTAATACGACTCACTATAGGAAGCTAACAACA
AAGAACAACAAACAACAAAGTCCGACTGAGAAGGAA 
CCACCATGGCTTCCAAGGTG-3′
Wild type a-globin:
5′-CTTAATACGACTCACTATAGGAAGCTTCTGGTCCAGTC
CGACTGAGAAGGAACCACCATGGCTTCCAAGGTG-3′
suPPleMentary MaterIal
Methods
Plasmid DNA transfection
DRG neurons were isolated and cultured as described in the section 
“Methods” of the main paper. HEK-293 cells (ATCC, Manassas, VA, 
USA) were cultured according to the supplier’s instructions and 
were replated approximately 16 h prior to transfection into 35 mm 
glass- bottomed dishes at ∼70% confluency. Immediately prior to 
transfection mix preparation, 75% of the cell culture media was 
replaced with the same volume of antibiotic-free cell culture media. 
The transfection mix was prepared in two parts, the first part con-
sisting of 2 μg of pEGFP-C1 plasmid (Clontech, Mountain View, 
CA, USA) and 200 μl OptiMEM, and the second part containing 
5 μl L2K and 200 μl OptiMEM. Each component was gently mixed, 
incubated at room temperature for 5 min before being combined, 
mixed again, and incubated at room temperature for a further 
20 min. The transfection mix was added dropwise to the cells and 
the dishes gently rocked to ensure adequate mixing. The cells were 
incubated in the presence of the transfection mix at 37°C for 3 h. 
After the incubation, 1.5 ml of the media was removed and replaced 
with the same volume of complete cell media. Cells were imaged 
16 h after transfection (see Methods for details).
Cloning
pRNA2-CB1R. CB1R transcript variant 1 was subcloned from a 
parent vector described previously (Guo and Ikeda, 2004) using 
the primers shown below.
Forward: 5′-GATCGAATTbCGCCACCATGGCCGGTGATTC
TAGGAATG-3′
(EcoRI site underlined, start codon in italics)
Reverse: 5′-GGCAACAAGGGGCTCAATGTGAGCGGCCGC
GATC-3′
(NotI site underlined, stop codon in italics)
The PCR product was cloned into the EcoRI and NotI sites of 
pRNA2 vector described in Williams et al. (2009).
pRNA2-GIRK4(S143T). Rat Kcnj5 containing the S143T (TCC to 
ACC) and H400 silent mutation (CAT to CAC) was subcloned 
from a parent vector described previously (Lei et al., 2000) using 
the primers shown below.
Forward: 5′-GATCGAATTCGCCACCATGGCCGGTGATTCT
AGGAATG-3′
(EcoRI site underlined, start codon in italics)
Reverse: 5′-GGCAACAAGGGGCTCAATGTGAGCGGCCGC
GATC-3′
(NotI site underlined, stop codon in italics) The PCR product 
was cloned into the EcoRI and NotI sites of pRNA2.
pRNA-G
oA
(G203T). Human GNAO1 containing the G203T (GGA 
to ACA) mutation was cut at BglII and NotI restriction sites from 
the pcDNA3.1 parental vector obtained from the Missouri S and T 
cDNA Resource Center (Rolla, MO, USA) and inserted into the cor-
responding sites in pRNA2.
pRNA2-Rluc and pRNA2-Fluc. Rluc (hRluc from phRG-TK) and 
Fluc (+luc from pGL3-Control; both from Promega) . For both 
constructs, the parental vector was first cut at the XbaI site and 
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Alfalfa mosaic virus:
5′-TACGACTCACTATAGGGAGATTTTTATTTTTAATTTTCT
TTCAAATACTTCCACCATGGCTTCCAAGGTG-3′
Tobacco mosaic virus:
5 ′-TACGACTCACTATAGGGAGATATTTTTACAACA
ATTACCAACAACAACAAACAACAAACAACATTACAA 
TTACTATTTACAATTACAATGGCTTCCAAGGTG-3′
RNA quantification
A260 method. 2 μl of stock mRNA was diluted in 98 μl TE buffer 
(pH 7.4). The absorbance of the diluted solution was measured at 
260 nm in a spectrophotometer (Biophotometer, Eppendorf).
Ribogreen method. The solution fluorescence-based assay was carried 
out using Quant-iT RiboGreen RNA Assay Kit (Life Technologies) 
according to the manufacturers instructions. Measurements 
were made in a 96-well format, using the “low-range” protocol. 
Fluorescence was measured with a Spectramax Gemini XS plate 
reader (Molecular Devices, Sunnyvale, CA, USA) using an excitation 
wavelength of 485 nm and emission wavelength of 525 nm.
Band intensity method. Samples containing 1 μl of each stock 
mRNA solution or 4 μl of RNA mass ladder (RiboRuler™ High 
Range RNA Ladder; Fermentas, Burlington, ON, Canada) were 
added to 2× RNA Loading Dye (Fermentas) and run on a 1% aga-
rose-formaldehyde gel. Gels were imaged using a Gel Logic 100 
Image Station (Carestream Health, Rochester, NY, USA) and mRNA 
mass calculated with Carestream Molecular Imaging 5.0 software 
using the RNA mass ladder as a standard.
mRNA transfection protocols
mRNA transfection of adherent neurons. This protocol has been 
optimized for the transfection of neurons cultured in 35 mm dishes. 
The neurons should be tightly adhered to the dishes to prevent 
loss of cells during the multiple media changes that are required 
for this procedure.
 1. Clone cDNA of interest into pRNA2.
 2. Prepare capped, polyadenylated mRNA from pRNA2 tem-
plate using mMESSAGE mMACHINE T7 ULTRA Kit, accor-
ding to manufacturers instructions.
 3. Before transfection, plate neurons in poly-l-lysine-coated 
35 mm dishes and culture until neurons are tightly adhered 
to the dish.
 4. For each transfection, 2 ml of transfection mix is prepared 
for each 35 mm dish. The mix consists of two components, 
which are made up separately. Lipofectamine component: Add 
4.1 μl Lipofectamine 2000–996 μl of OptiMEM. Mix gen-
tly. RNA component: Add 3.1 μg of mRNA (+3.1 μg EGFP 
mRNA, if required) to OptiMEM to a final volume of 1 ml. 
Mix gently.
 5. Incubate each component for 5 min at room temperature.
 6. Combine the two transfection mix components, invert a few 
times to mix and incubate for 30 min at room temperature.
 7. Remove cell growth media and wash plated cells twice with 
Dulbecco’s Phosphate buffered saline (DPBS).
 8. Remove DPBS and slowly add transfection mix to cells. 
Incubate at 37°C for 1 h.
 9. Slowly remove transfection mix and carefully wash cells twice 
with DPBS.
 10. Add growth media and incubate at 37°C overnight.
Suspension transfection of mRNA into rat dissociated superior 
cervical ganglion neurons. This protocol is optimized for a sin-
gle transfection of rat dissociated SCG neurons isolated from 
one rat. The protocol is arranged so that the transfection mix 
is ready at the same time that the dissociated cells are normally 
plated. For other dissociation protocols, the timings should be 
adjusted as appropriate. The number and density of cells plated 
in each dish is well suited for a typical patch clamp recording 
experiment.
 1. Clone cDNA of interest into pRNA2.
 2. Prepare capped, polyadenylated mRNA from pRNA2 tem-
plate using mMESSAGE mMACHINE T7 ULTRA Kit, accor-
ding to manufacturers instructions.
 3. Isolate SCG neurons and begin dissociation as normal.
 4. 45 min before dissociated neurons are normally plated (for 
SCG neurons, ∼ 25 min after start of the enzymatic disso-
ciation step), begin preparation of the RNA transfection 
mix. 2 ml of transfection mix is prepared for each tran-
sfection. The mix consists of two components that are 
made up separately. Lipofectamine component: Add 4.1 μl 
Lipofectamine 2000–996 μl of OptiMEM. Mix gently. RNA 
component: Add 3.1 μg of mRNA (+3.1 μg GFP mRNA, 
if required) to OptiMEM to a total volume of 1 ml. Mix 
gently.
 5. Incubate each component for 5 min at room temperature.
 6. Combine the two transfection mix components, invert 
a few times to mix. Incubate mix for 30 min at room 
temperature.
 7. After digestion of SCG neurons for 1 h, dissociate neurons by 
vigorously shaking flask by hand for 10 s. Add 5 ml growth 
media to neurons, transfer suspension to a 15 ml centrifuge 
tube and spin at 50× g for 6 min.
 8. Remove supernatant and resuspend pellet in 10 ml OptiMEM. 
Split the suspension of cells into one aliquot of 4 ml (for 
untransfected cells) and one aliquot of 6 ml (for transfected 
cells). Spin at 50× g for 6 min.
 9. Remove supernatant from the 4 ml aliquot and resuspend 
neurons in 400 μl of growth media. Plate 200 μl of cell suspen-
sion in each 35 mm dish. Incubate at 37°C until required for 
experiments.
10. Remove media from 6 ml aliquot and resuspend neurons 
in transfection mix (which, by now, should have incuba-
ted at room temperature for ∼30 min). Gently pipette up 
and down to resuspend pellet. Transfer cell suspension to 
a 0.15% agarose-coated 35 mm dish. Incubate at 37°C for 
1 h.
11. Add 3 ml of growth media to dish of transfected cells. 
Carefully remove suspension of cells (∼ 5 ml) and transfer to 
15 ml Falcon tube and spin at 50 g for 6 min.
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ried out and the consistency of Rluc expression compared. Five dif-
ferent mRNA preparations were transcribed on different occasions, 
using two different batches of transcription kit. Firstly, methods 
to determine the concentration of the mRNA were assessed. Three 
different methods of RNA quantification were used: absorbance at 
260 nm (A260), a solution-based fluorescence assay (Ribogreen), 
and band intensity measurements. As shown in Figure S3i, mRNA 
concentrations were always highest using A260 > Ribogreen > band 
intensity. The measurement of mRNA concentration using the 
band intensity is likely to have the greatest potential for accuracy 
because it enables mRNA of the correct size to be quantified. 
However, in these experiments, the intensity of the mass ladder 
bands were not very consistent (Figure S3ii) and accurate quan-
tification of the band intensity was difficult. For this reason, the 
mRNA concentrations used for transfection were calculated using 
the Ribogreen method.
DRG neurons were incubated for 1 h with a transfection mix 
containing 20, 60, or, 200 ng of the different Rluc mRNA prepa-
rations, and 0.24 μl of L2K. 16 h after transfection, Rluc activity 
was measured from cell lysates. Rluc activity was normalized to 
that of control construct A within each experiment. As shown in 
Figure S3iii, a range of luciferase activities resulted from different 
Rluc preparations: at 60 ng, from 93 ± 22% (Prep B) to 163 ± 25% 
(Prep E) of the control activity. As indicated by the large error bars 
(Figure S3iii), there was also an unexpectedly high level of vari-
ability between experiments occurred (cf. Figures 1 and 2). These 
experiments show that substantial variation in protein expression 
occurs between different mRNA preps, which make interpretation 
of small differences in expression difficult to ascribe to changes to 
the mRNA transcript.
12. Remove supernatant and resuspend cells in 600 μl of com-
plete media. Plate 200 μl of cell suspension in each 35 mm 
dish. Incubate at 37°C overnight.
results
Cationic lipid-mediated plasmid DNA transfection of DRG neurons
Preparation and transfection of plasmid DNA using cationic lipid is 
a simple, well-established technique that is effective in a variety of 
dividing cells types. The ability to use this method for heterologous 
expression in cultures of adult peripheral neurons would be a great 
advantage over the more laborious methods commonly used. To 
assess heterologous expression in adult neurons using plasmid DNA 
transfection, DRG cultures were transfected using 2 μg pEGFP-C1 
plasmid DNA vector and 5 μl L2K. The resulting GFP expression 
was monitored using imaging by fluorescence microscopy. For a 
positive control, HEK-293 cells were transfected using the same 
conditions in parallel experiments. As shown in Figure S1, transfec-
tion using conditions that result in high levels of EGFP expression in 
HEK-293 cells do not result in measurable GFP expression in DRG 
neurons. Any fluorescence visible in the transfected neurons was 
indistinguishable from autofluorescence present in untransfected 
cells. These results suggest that cationic lipid-mediated plasmid 
DNA transfection is unsuitable method for heterologous expression 
in DRG neurons and alternative techniques are necessary.
Consistency of mRNA preparations
In order to interpret results from experiments when mRNA from 
more than one transcription reaction is used, it is important to 
establish that mRNA preparations are consistent. For this reason, 
multiple transcription reactions of the same Rluc template were car-
Figure S1 | Cationic lipid-mediated plasmid DNA transfection of Drg neurons. (A) Phase and fluorescence image of untransfected DRG neurons. (B) Phase 
and fluorescence image of DRG neurons transfected with 2 μg pEGFP-C1 DNA, 16 h after transfection (C) Phase and fluorescence image of HEK-293 cells 
transfected with 2 μg pEGFP-C1 DNA, 16 h after transfection. 100 μm scale bar (for all images).
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Figure S2 | effect of expression of an additional coding mrNA on Rluc 
expression. Expression of Rluc and an additional protein (Fluc) was measured 
simultaneously in lysates from DRG neurons transfected with 100 ng of Rluc 
mRNA and 1–300 ng of Fluc mRNA. Cells were incubated with transfection 
mix containing the mRNA and 0.24 μl L2K for 1 h. Rluc and Fluc activities 
were measured 16 h after transfection using the Dual Luciferase Reporter 
Assay System. Rluc activity (•) was normalized to the luciferase activity of cell 
lysates transfected with 100 ng Rluc mRNA alone. Fluc activity (•) was 
normalized to the maximum Fluc activity within an experiment (n = 3). The 
same Ruc activity is presented in Figure 1vi.
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Figure S3 | Assessment of the consistency of Rluc mrNA preparations. 
The consistency of luciferase expression from mRNA preparations transcribed 
from the same template was investigated. (i) Measurement of Rluc mRNA 
concentrations using three different methods. Each section of the chart (A–E) 
represents a different Rluc mRNA preparation. Different colors represent 
different mRNA preparations and are consistent throughout all parts of the 
figure. The concentration of each Rluc mRNA preparation was determined using 
the absorbance at 260 nm (A260l), a fluorescent dye-based solution method 
(Ribogreen; n), and by measuring the intensity of a band in an ethidium bromide 
stained-gel (Gel intensity  ¨). Concentrations were measured in duplicate on four 
different occasions. The mean Rluc concentration, as measured by Ribogreen, is 
represented by a dashed line (- - -). (ii) A representative ethidium bromide-
stained gel containing the five Rluc mRNA preparations (A–E) and the RNA 
mass ladder from which the mass of the Rluc preparations were calculated. (iii) 
Graph showing luciferase activity of lysates from DRG neurons transfected with 
20, 600, and 200 ng of the five Rluc mRNA preparations (A–E). Data were 
normalized to luciferase activity of neurons transfected with 100 ng of Rluc 
mRNA preparation A (n = 4).
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Figure S4 | mrNA template plasmids (A) Maps of the plasmid vectors used 
templates for mRNA transcription. cDNA of interest is cloned into a multiple 
cloning sequence (MCS) downstream of a T7 promoter (T7). The plasmids 
contain an EGFP sequence that can be used for expression of an EGFP fusion 
protein. EGFP can be removed during cloning by using a 5′ site restriction site in 
the MCS and NotI. pRNA2 (i) can be linearized downstream of the b-globin 
3′-UTR sequences using SwaI or PmeI. This vector requires enzymatic 
polyadenylation. (ii) pRNA2-(A)128 contains a poly(A) sequence ((A)128) and does 
not require enzymatic polyadenylation. This vector should be linearized by AarI, 
AloI, BaeI, BsaXI, or BaeI downstream of (A)128 to ensure an optimal poly(A) tail 
is transcribed. This vector can also be linearized upstream of (A)128 using SwaI or 
PmeI, if enzymatic polyadenylation is preferred. Relevant unique restriction sites 
are indicated in blue. Parentheses indicate that multiple cleavage sites exist, but 
that the other sites are located in regions of the plasmid that are not transcribed. 
Therefore, these sites can be used for linearization. (B) Multiple cloning 
sequence of both pRNA vectors. Unique restriction sites are indicated in blue. 
The location of the T7 promoter (white arrow), the first transcribed base and the 
start of the EGFP sequence (green arrow) are indicated.
